Cargando…
Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities
Chaperone-mediated autophagy (CMA) is a protein degradation mechanism through lysosomes. By targeting the KFERQ motif of the substrate, CMA is responsible for the degradation of about 30% of cytosolic proteins, including a series of proteins associated with neurodegenerative diseases (NDs). The fact...
Autores principales: | Wang, Yi-Ting, Lu, Jia-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323300/ https://www.ncbi.nlm.nih.gov/pubmed/35883693 http://dx.doi.org/10.3390/cells11142250 |
Ejemplares similares
-
Targeting chaperone-mediated autophagy for Parkinson’s disease therapy
por: Wang, Yi-Ting, et al.
Publicado: (2023) -
Chaperone‐mediated autophagy: Molecular mechanisms, biological functions, and diseases
por: Yao, Ruchen, et al.
Publicado: (2023) -
Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders
por: Alfaro, Iván E., et al.
Publicado: (2019) -
Chaperone-Mediated Autophagy in Neurodegenerative Diseases and Acute Neurological Insults in the Central Nervous System
por: Kanno, Haruo, et al.
Publicado: (2022) -
Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2021)